Logo image of CRBN.AS

CORBION NV (CRBN.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:CRBN - NL0010583399 - Common Stock

18.2 EUR
-0.12 (-0.66%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

5

CRBN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 72 industry peers in the Chemicals industry. CRBN has an average financial health and profitability rating. CRBN is cheap, but on the other hand it scores bad on growth. With these ratings, CRBN could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CRBN was profitable.
CRBN had a positive operating cash flow in the past year.
CRBN had positive earnings in each of the past 5 years.
Each year in the past 5 years CRBN had a positive operating cash flow.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

CRBN has a Return On Assets of 4.55%. This is in the better half of the industry: CRBN outperforms 68.06% of its industry peers.
With a decent Return On Equity value of 9.12%, CRBN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.19%, CRBN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 7.08%.
The last Return On Invested Capital (9.19%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROIC 9.19%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 5.11%, CRBN is doing good in the industry, outperforming 63.89% of the companies in the same industry.
In the last couple of years the Profit Margin of CRBN has grown nicely.
CRBN has a better Operating Margin (8.68%) than 62.50% of its industry peers.
In the last couple of years the Operating Margin of CRBN has declined.
CRBN's Gross Margin of 26.10% is on the low side compared to the rest of the industry. CRBN is outperformed by 63.89% of its industry peers.
CRBN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CRBN has been reduced compared to 1 year ago.
Compared to 5 years ago, CRBN has less shares outstanding
The debt/assets ratio for CRBN has been reduced compared to a year ago.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.73 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
CRBN has a Altman-Z score (2.73) which is comparable to the rest of the industry.
The Debt to FCF ratio of CRBN is 4.95, which is a neutral value as it means it would take CRBN, 4.95 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.95, CRBN is doing good in the industry, outperforming 70.83% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.39, CRBN perfoms like the industry average, outperforming 56.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Altman-Z 2.73
ROIC/WACC1.45
WACC6.36%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

CRBN has a Current Ratio of 1.21. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.21, CRBN is not doing good in the industry: 81.94% of the companies in the same industry are doing better.
A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
With a Quick ratio value of 0.60, CRBN is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.99%.
CRBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.47% yearly.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
Measured over the past years, CRBN shows a small growth in Revenue. The Revenue has been growing by 5.70% on average per year.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

Based on estimates for the next years, CRBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.24% on average per year.
Based on estimates for the next years, CRBN will show a decrease in Revenue. The Revenue will decrease by -1.71% on average per year.
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.25, the valuation of CRBN can be described as correct.
Based on the Price/Earnings ratio, CRBN is valued a bit cheaper than the industry average as 73.61% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.54. CRBN is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 11.96 indicates a reasonable valuation of CRBN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 75.00% of the companies listed in the same industry.
CRBN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.25
Fwd PE 11.96
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CRBN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 66.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CRBN is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.62
EV/EBITDA 7.71
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRBN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 19.62% in the coming years.
PEG (NY)0.44
PEG (5Y)0.33
EPS Next 2Y22.97%
EPS Next 3Y19.62%

6

5. Dividend

5.1 Amount

CRBN has a Yearly Dividend Yield of 3.49%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.19, CRBN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.27, CRBN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.49%

5.2 History

The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

56.19% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.19%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CORBION NV

AMS:CRBN (12/12/2025, 7:00:00 PM)

18.2

-0.12 (-0.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31
Earnings (Next)N/A N/A
Inst Owners90.59%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.06B
Revenue(TTM)1.30B
Net Income(TTM)66.20M
Analysts78.57
Price Target23.92 (31.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.49%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.96%
PT rev (3m)2.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)-1.66%
Valuation
Industry RankSector Rank
PE 16.25
Fwd PE 11.96
P/S 0.82
P/FCF 10.62
P/OCF 6.29
P/B 1.46
P/tB 1.67
EV/EBITDA 7.71
EPS(TTM)1.12
EY6.15%
EPS(NY)1.52
Fwd EY8.36%
FCF(TTM)1.71
FCFY9.41%
OCF(TTM)2.89
OCFY15.89%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.44
PEG (5Y)0.33
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROCE 10.92%
ROIC 9.19%
ROICexc 9.57%
ROICexgc 10.55%
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
FCFM 7.7%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Debt/EBITDA 1.43
Cap/Depr 81.01%
Cap/Sales 5.3%
Interest Coverage 7.03
Cash Conversion 85.4%
Profit Quality 150.76%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.73
F-Score6
WACC6.36%
ROIC/WACC1.45
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.83%
EBIT Next 3Y37.35%
EBIT Next 5Y26.73%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


Can you provide the valuation status for CORBION NV?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CRBN stock?

The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 16.25 and the Price/Book (PB) ratio is 1.46.


Can you provide the dividend sustainability for CRBN stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.19%.